Integration of Liquid Biopsy for Optimal Management of Non-small Cell Lung Cancer
Molecular profiling of tumors from patients plays a crucial role in precision oncology. While tumor tissue-based genomic testing remains the gold standard in clinical management of patients with non-small cell lung cancer, advances in genomic technologies, the analysis of various bodily fluids, main...
Saved in:
| Main Authors: | Yuko Oya, Ichidai Tanaka, Ross A. Soo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2025-07-01
|
| Series: | Tuberculosis and Respiratory Diseases |
| Subjects: | |
| Online Access: | http://e-trd.org/upload/pdf/trd-2024-0146.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquid biopsies in cancer
by: Hang Yin, et al.
Published: (2025-03-01) -
Clinical utility of liquid biopsy next-generation sequencing for advanced non-small cell lung cancer in the Netherlands
by: Tessa J. J. de Bitter, et al.
Published: (2025-08-01) -
Diagnosis of early-stage non-small cell lung cancer using DNA methylation in tissue and plasma
by: Lei Li, et al.
Published: (2025-11-01) -
Can Liquid Biopsy Cancer Research Offering Personalized Cancer Treatment in Gynecology be a Realistic Expectation?
by: Felix Wong, et al.
Published: (2023-06-01) -
Identification of minimal residual disease using the clonesight test for ultrasensitive ctDNA detection to anticipate late relapse in early breast cancer
by: Iñaki Comino-Méndez, et al.
Published: (2025-05-01)